-
Medical journals
- Career
Monitoring The Important Mycotoxin Biomarkers (ochratoxin A, aflatoxin Mj) in the Czech Population
Authors: F. Malíř; V. 'ostrý; M. Černá 2; J. Kačerovský 3; T. Roubal; J. 'škarková; M. Brndiar 3; P. Fixa 4
Authors‘ workplace: Zdravotní ústav Centrum hygienických laboratoří - oddělení xenobiochemie, NRL pro biomarkery mykotoxinů a mykotoxiny v potravinách, Hradec Králové Státní zdravotní ústav, Praha, Centrum hygieny potravinových řetězců, Národní referenční centrum pro mikrosk
Published in: Čas. Lék. čes. 2004; : 691-696
Category:
Overview
Background.
In among mycotoxins, secondary metabolites of toxinogenic moulds, ochratoxin A and aflatoxins occupy a prominent pláce. These mycotoxins háve been - as etiologic agents - associated with a wide numbers of acute and chronic human diseases including mycotoxicoses like Balkán endemic nephropathy oř liver cancer. While the risk of acute toxic effects of ochratoxin A and aflatoxin Bt is usually considered to be minimal in the Czech Republic, the situation is different as far as the risk of the latě toxic effects (particularly carcinogenic), which result from a single oř repeated intake of low doses of these mycotoxins from foodstuffs is concerned. Methods and Results. The presence of ochratoxin A and aflatoxins in human environment has been monitored within the program "Monitoring the health statě of the population". As for ochratoxin A, 2206 samples of blood sérum were investigated, 2077 (94 %) of them turned out to be positive (with levels >0,l |xg.l4), the average was 0,28 |xg.r\ the medián was 0,2 ixg.l"1, and the percentile (90 %) was 0,5 |xg.r\ The ochratoxin A levels ranged from 0,1 to 13,7 |xg.r' of sera. The presence of ochratoxin A was also analyzed in 30 samples of human kidneys; 12 samples were positive (with levels >0,l |xg.r'), the average was 0,07 ixg.kg"1, the medián was 0,05 |xg.kg"\ As for aflatoxins, in 1997-1998 the presence of aflatoxin Mj was investigated in 205 samples of human urine; 118 samples (58 %) were positive (with levels >125 pg.l"1 of urine).Conclusions. When calculated to a concentration of creatinine in urine, the average was 391 pg.g"1, the medián was127 pg.g', and the percentile (90 %) was 585 pg.g'. The aflatoxin Mj levels ranged from 19 to 19 219 pg.g' of creatinineKey words:
mycotoxins, human exposure, risk assessment, monitoring, biomarkers
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Article was published inJournal of Czech Physicians
-
All articles in this issue
- Thromboelastography in Liver Transplantation, a Comparison withConventional Laboratory Tests
- Nuclear Factor kappa B in the Treatment of Inflammatory and Tumor Diseases
- Evaluation ofthe Clinical Effectivity and Toxicity ofthe FDN Regimen (Fludarabin, Mitoxantron, Dexamethason) in Patients with FoUicular Lymphoma
- Monitoring The Important Mycotoxin Biomarkers (ochratoxin A, aflatoxin Mj) in the Czech Population
- Proteasome inhibitors - New Option in the Treatment of Tumor Diseases
- A Severe Čase with Respiratory Insufficiency
- Čase Reports ofPatients with a Marker Chromosome
- ABC of Smoking Cessation. Use ofSimple Advice and Behavioural Support
- Novel Genetic Approaches to the Resolutionof Complex Diseases
- Treatment in the Primary Prevention of Stroke - Still Not Fully Used Option
- Genetic Causes ofthe Thyroid Carcinomas
- Regression of Atherosclerotic Plaques during Treatment with Statins
- Nutrition Genomics
- Journal of Czech Physicians
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Regression of Atherosclerotic Plaques during Treatment with Statins
- Čase Reports ofPatients with a Marker Chromosome
- A Severe Čase with Respiratory Insufficiency
- Evaluation ofthe Clinical Effectivity and Toxicity ofthe FDN Regimen (Fludarabin, Mitoxantron, Dexamethason) in Patients with FoUicular Lymphoma
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career